FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103251054> ?p ?o ?g. }

• W2103251054 abstract "We investigated the interrelationship and the influence of thyroid-stimulating antibodies (TSAb), TSH-blocking antibodies (TSHBAb), and of radioiodine (131I)-induced thyroid damage in the early (within 1 yr) outcome of thyroid function in hyperthyroid patients with Graves' disease (GD) treated with 131I. TSAb, TSHBAb, and ultrasound thyroid volume (as an index of thyroid damage) were simultaneously measured before and at 1, 3, 6, and 12 months after 131I in 31 GD patients. One year after radioiodine, 9.7% of patients were hyperthyroid (Hyper-group), requiring methimazole; 12.9% were euthyroid (Eu-group); and 77.4% were hypothyroid (Hypo-group). Pretreatment thyroid volume in the Eu-group and Hyper-group was significantly greater (P = 0.009) than in the Hypo-group. Pre-131I TSAb levels were higher in the Hyper-group vs. the Hypo-group (P = 0.01) or the Eu-group (P = 0.03). A significant post-131I increase in TSAb levels occurred in 66% of patients developing hypothyroidism but not in those remaining hyperthyroid. After 131I, TSHBAb appeared in 7 patients, in all but one associated with high levels of TSAb. One year after radioiodine: 1) the mean percent reduction in thyroid volume was greater in the Hypo-group (80.7%) or the Eu-group (83.5%) than in the Hyper-group (35.7%) (P = 0.007 and 0.0033 respectively); 2) hypothyroid patients had smaller (P = 0.0058) post-131I thyroids than hyperthyroid patients; and 3) TSAb were still elevated in 75% hypothyroid patients, but all of them had a thyroid volume < or = 8 mL, indicating major postradioiodine gland damage.1) the early outcome of thyroid function after 131I for GD is mainly related to pretreatment thyroid volume and to the degree of its reduction after therapy; 2) high TSAb levels before 131I are associated with a relative resistance to therapy; 3) a postradioiodine increase in TSAb levels is related to the development of hypothyroidism; and 4) the concomitant appearance of TSHBAb and disappearance of TSAb are not frequent after 131I and play a role in the development of early postradioiodine hypothyroidism only in a minority of patients." @default.
• W2103251054 created "2016-06-24" @default.
• W2103251054 creator A5003531480 @default.
• W2103251054 creator A5008112186 @default.
• W2103251054 creator A5014279456 @default.
• W2103251054 creator A5030712568 @default.
• W2103251054 creator A5032543047 @default.
• W2103251054 creator A5039854079 @default.
• W2103251054 creator A5062979548 @default.
• W2103251054 creator A5071641712 @default.
• W2103251054 creator A5083785655 @default.
• W2103251054 creator A5087338076 @default.
• W2103251054 creator A5091827788 @default.
• W2103251054 date "1998-01-01" @default.
• W2103251054 modified "2023-09-30" @default.
• W2103251054 title "Outcome of Thyroid Function in Graves’ Patients Treated with Radioiodine: Role of Thyroid-Stimulating and Thyrotropin-Blocking Antibodies and of Radioiodine-Induced Thyroid Damage1" @default.
• W2103251054 cites W1424218273 @default.
• W2103251054 cites W1891948454 @default.
• W2103251054 cites W1965602277 @default.
• W2103251054 cites W1970867452 @default.
• W2103251054 cites W1971939771 @default.
• W2103251054 cites W2000364076 @default.
• W2103251054 cites W2008453353 @default.
• W2103251054 cites W2011275871 @default.
• W2103251054 cites W2014302771 @default.
• W2103251054 cites W2029814764 @default.
• W2103251054 cites W2047477206 @default.
• W2103251054 cites W2051202188 @default.
• W2103251054 cites W2056377104 @default.
• W2103251054 cites W2083432495 @default.
• W2103251054 cites W2086051211 @default.
• W2103251054 cites W2140695275 @default.
• W2103251054 cites W2146733264 @default.
• W2103251054 cites W2165071992 @default.
• W2103251054 cites W2314427644 @default.
• W2103251054 cites W2413156722 @default.
• W2103251054 cites W3023517638 @default.
• W2103251054 doi "https://doi.org/10.1210/jcem.83.1.4492" @default.
• W2103251054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9435414" @default.
• W2103251054 hasPublicationYear "1998" @default.
• W2103251054 type Work @default.
• W2103251054 sameAs 2103251054 @default.
• W2103251054 citedByCount "55" @default.
• W2103251054 countsByYear W21032510542012 @default.
• W2103251054 countsByYear W21032510542015 @default.
• W2103251054 countsByYear W21032510542017 @default.
• W2103251054 countsByYear W21032510542018 @default.
• W2103251054 countsByYear W21032510542019 @default.
• W2103251054 countsByYear W21032510542020 @default.
• W2103251054 countsByYear W21032510542021 @default.
• W2103251054 countsByYear W21032510542022 @default.
• W2103251054 crossrefType "journal-article" @default.
• W2103251054 hasAuthorship W2103251054A5003531480 @default.
• W2103251054 hasAuthorship W2103251054A5008112186 @default.
• W2103251054 hasAuthorship W2103251054A5014279456 @default.
• W2103251054 hasAuthorship W2103251054A5030712568 @default.
• W2103251054 hasAuthorship W2103251054A5032543047 @default.
• W2103251054 hasAuthorship W2103251054A5039854079 @default.
• W2103251054 hasAuthorship W2103251054A5062979548 @default.
• W2103251054 hasAuthorship W2103251054A5071641712 @default.
• W2103251054 hasAuthorship W2103251054A5083785655 @default.
• W2103251054 hasAuthorship W2103251054A5087338076 @default.
• W2103251054 hasAuthorship W2103251054A5091827788 @default.
• W2103251054 hasBestOaLocation W21032510541 @default.
• W2103251054 hasConcept C126322002 @default.
• W2103251054 hasConcept C134018914 @default.
• W2103251054 hasConcept C178790620 @default.
• W2103251054 hasConcept C185592680 @default.
• W2103251054 hasConcept C2776652619 @default.
• W2103251054 hasConcept C2777195454 @default.
• W2103251054 hasConcept C2993291352 @default.
• W2103251054 hasConcept C526584372 @default.
• W2103251054 hasConcept C539932907 @default.
• W2103251054 hasConcept C71924100 @default.
• W2103251054 hasConceptScore W2103251054C126322002 @default.
• W2103251054 hasConceptScore W2103251054C134018914 @default.
• W2103251054 hasConceptScore W2103251054C178790620 @default.
• W2103251054 hasConceptScore W2103251054C185592680 @default.
• W2103251054 hasConceptScore W2103251054C2776652619 @default.
• W2103251054 hasConceptScore W2103251054C2777195454 @default.
• W2103251054 hasConceptScore W2103251054C2993291352 @default.
• W2103251054 hasConceptScore W2103251054C526584372 @default.
• W2103251054 hasConceptScore W2103251054C539932907 @default.
• W2103251054 hasConceptScore W2103251054C71924100 @default.
• W2103251054 hasLocation W21032510541 @default.
• W2103251054 hasLocation W21032510542 @default.
• W2103251054 hasOpenAccess W2103251054 @default.
• W2103251054 hasPrimaryLocation W21032510541 @default.
• W2103251054 hasRelatedWork W1988507778 @default.
• W2103251054 hasRelatedWork W2006971532 @default.
• W2103251054 hasRelatedWork W2011761361 @default.
• W2103251054 hasRelatedWork W2011960454 @default.
• W2103251054 hasRelatedWork W2039456755 @default.
• W2103251054 hasRelatedWork W2076638246 @default.
• W2103251054 hasRelatedWork W2077091297 @default.
• W2103251054 hasRelatedWork W2356193271 @default.
• W2103251054 hasRelatedWork W3181036828 @default.
• W2103251054 hasRelatedWork W2009143186 @default.
• W2103251054 isParatext "false" @default.
• W2103251054 isRetracted "false" @default.

• next